510(k) Report

FDA applicant

Altaviz, LLC

Irvine, CA3 decisions2022–20251 recall

FDA records 3 decisions for Altaviz, LLC (Irvine, CA) from 2022 to 2025: 3 510(k) clearances. Most are in product codes FMI (Needle, Hypodermic, Single Lumen) and QLY (Ophthalmic Syringe). Since 2016 its 510(k)s took a median of 90 days from receipt to decision, against 176 for FDA’s reviews in the same codes and years. Its devices cite 4 predicates, 1 of them its own earlier devices. 1 recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, general hospital panel, where it files most

How often FDA has decided Altaviz, LLC’s devices, and how often a recall has named them.

FDA decisions per year

1in 2025

2022: 12023: 12025: 1
2022high 1 (2022) · low 0 (2024)2026

2026 so far, outlined.

Recalls per year

1in 2023

2023: 1
2022high 1 (2023) · low 0 (2022)2026

Class I Class II/III not classified

FIG. 1 — Altaviz, LLC by year, 2022–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Altaviz, LLC’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report